Bowhead Specialty vs Global Indemnity
BOW and GBLI side by side, both in fire, marine, and casualty insurance. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BOW and GBLI compare
Bowhead Specialty is the larger company, worth 3.3 times as much as Global Indemnity ($1.1B against $339M).
On earnings, Global Indemnity is cheaper: it trades at 10.5× trailing earnings, against 18.4× for Bowhead Specialty.
Bowhead Specialty grew revenue faster over the last twelve months (25.0% versus 3.0% for Global Indemnity).
Bowhead Specialty keeps more of each dollar of sales as profit, with a net margin of 10.1% compared with 6.7% at Global Indemnity.
Global Indemnity pays a dividend yielding 6.4%; Bowhead Specialty does not pay one.
Global Indemnity scores higher on the StockData Score (13 against 6 for Bowhead Specialty), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BOW | GBLI |
|---|---|---|
| Size and price | ||
| Market cap | $1.1B | $339M |
| Share price | $34.13 | $22.00 |
| Change, 1 year | 27.5% | −23.0% |
| Change, 5 years | – | −16.2% |
| Beta (5Y) | 0.33 | 0.18 |
| Employees | 296 | 286 |
| StockData Score | ||
| Total score | 6 | 13 (better) |
| Valuation score | 1 | 6 (better) |
| Growth score | 3 (better) | 0 |
| Performance score | 2 | 2 |
| Health score | 0 | 0 |
| Dividend score | 0 | 5 (better) |
| Valuation | ||
| P/E | 18.4× | 10.5× (better) |
| P/S | 1.8× | 0.7× (better) |
| P/B | 2.4× | 0.5× (better) |
| EV/EBITDA | 11.1× | 3.5× (better) |
| P/FCF | 3.4× | – |
| PEG | 0.37 | – |
| FCF yield | 29.2% | – |
| Fair value | $26.38 | $38.03 |
| Margin of safety | −29.4% | 42.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 25.0% (better) | 3.0% |
| Revenue growth, 5Y average | – | −5.1% |
| Net income growth (TTM) | 25.7% (better) | 9.9% |
| EPS growth (TTM) | 26.7% (better) | 9.4% |
| Profitability | ||
| Net margin | 10.1% (better) | 6.7% |
| FCF margin | 53.5% | – |
| Return on equity | 14.1% (better) | 4.4% |
| Financial health | ||
| Altman Z-score | 0.61 | 0.71 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | – | 6.4% |
| Payout ratio | – | 81.9% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | 7.0% |
| Shareholder yield | 0.00% | 6.4% (better) |
| Ownership | ||
| Held by institutions | 92.7% | 18.6% |
| Held by insiders | 76.6% | 27.6% |
| Insider net buying, 12 months | – | $0 |
| Short interest, % of float | 19.6% | 0.06% |
Go deeper
- BOW stock overview
- BOW income statement
- BOW valuation and score
- GBLI stock overview
- GBLI income statement
- GBLI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.